A breast cancer vaccine strategy will need to effectively train cytotoxic T cells to recognize and kill transformed cells while sparing normal ones. Cancer Control: Journal of the Moffitt Cancer Center
New systemic therapies are urgently needed for triple-negative breast cancer tumors because hormonal therapies and HER2-targeted agents are ineffective. Nature Reviews Clinical Oncology
Investigations into the microenvironment of tumor cells suggest that aspects of inflammation promote tumor growth. But Dr. David Kerr finds a gap in our understanding of good and bad inflammation. Medscape Hematology-Oncology
Immunohistochemical assessment of cell cycle proteins may help distinguish normal and benign conditions of the cervix from precursor lesions of cervical carcinoma. American Journal of Clinical Pathology
